Polygenic Score for the Prediction of Postoperative Nausea and Vomiting: A Retrospective Derivation and Validation Cohort Study.
Nicholas J DouvilleLisa BastaracheJing HeKuan-Han H WuBrett VanderwerffEmily M BertucciWhitney E HornsbyAdam LewisElizabeth S JewellSachin KheterpalNirav J ShahMichael R MathisMilo C EngorenChristopher B DouvilleIda SurakkaCristen J WillerMiklos D KertaiPublished in: Anesthesiology (2024)
Standardized polygenic risk was associated with PONV in all three of our models, but the genetic influence was smaller than exerted by clinical risk factors. Specifically, a patient with a polygenic risk score > 1 standard deviation above the mean, has 2-3% greater odds of developing PONV when compared to the baseline population, which is at least an order of magnitude smaller than the increase associated with having prior PONV/motion sickness (55%), having a history of migraines (17%), or being female (83%), and is not clinically significant. Furthermore, the use of a polygenic risk score does not meaningfully improve discrimination compared to clinical risk factors and is not clinically useful.